New Breeding techniques: Covid vaccine reopens the debate

Posted on

Researchers at the Illinois University found that Crispr-Cas9 is more efficient in some parts of the genome, notably the less-tightly wound regions of the genome. The distribution of Covid-19 vaccines around Europe reopens the debate on under which circumstances NBTs can be used or not, while in China, cutting-edge research is underway, and scientists may have discovered a way to increase the compatibility between pig and human organs for implants. However, the Commission plans to dedicate €5 million to finance research on biotechnologies under the Horizon Europe programme.

full note available on FE Members’ area